ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland.
| Revenue (TTM) | $8.29B |
| Gross Profit (TTM) | $1.98B |
| EBITDA | $523.48M |
| Operating Margin | 9.41% |
| Return on Equity | 0.29% |
| Return on Assets | 0.97% |
| Revenue/Share (TTM) | $107.96 |
| Book Value | $121.55 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | 1.58 |
| EV/Revenue | 1.827 |
| EV/EBITDA | 22.76 |
| Quarterly Earnings Growth (YoY) | -63.30% |
| Quarterly Revenue Growth (YoY) | 1.20% |
| Shares Outstanding | $77.15M |
| Float | $77.10M |
| % Insiders | 0.44% |
| % Institutions | 108.37% |
Volatility is currently contracting
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced a multi-year collaboration with Anthropic to bring Claude's AI capabilities across the clinical trial lifecycle. The collaboration further advances ICON's digital innovation and AI strategy, and builds on Orbis – ICON's secure, governed, agentic AI platform. Through this collaboration, ICON will work closely with Anthropic's Life Sciences research team to explore and apply cutting-edge technologies that can accelerate innovation a.
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
DUBLIN--(BUSINESS WIRE)--ICON Schedules Second Quarter 2026 Earnings Conference Call.
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors?
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating: ICON plc (NASDAQ: ICLR) shareholders should email fletcher@fmoorelaw.com What is the Investigation About ? On February 12, 2026, ICON issued a press release entitled "ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ICLR and any ticker you trade — then tracks every position and per-strategy win rate.
